BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 184 filers reported holding BLUEBIRD BIO INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $71,000 | +54.3% | 11,212 | 0.0% | 0.01% | +50.0% |
Q2 2022 | $46,000 | -14.8% | 11,212 | 0.0% | 0.00% | +33.3% |
Q1 2022 | $54,000 | -51.8% | 11,212 | 0.0% | 0.00% | -66.7% |
Q4 2021 | $112,000 | -47.7% | 11,212 | 0.0% | 0.01% | -60.9% |
Q3 2021 | $214,000 | -40.4% | 11,212 | 0.0% | 0.02% | -34.3% |
Q2 2021 | $359,000 | +6.2% | 11,212 | 0.0% | 0.04% | 0.0% |
Q1 2021 | $338,000 | -33.7% | 11,212 | -4.8% | 0.04% | -34.0% |
Q4 2020 | $510,000 | -19.8% | 11,783 | 0.0% | 0.05% | -23.2% |
Q3 2020 | $636,000 | -11.5% | 11,783 | 0.0% | 0.07% | -21.6% |
Q2 2020 | $719,000 | +13.2% | 11,783 | -14.7% | 0.09% | +27.5% |
Q1 2020 | $635,000 | -50.1% | 13,812 | -4.8% | 0.07% | -36.7% |
Q4 2019 | $1,273,000 | -4.4% | 14,507 | 0.0% | 0.11% | +4.8% |
Q3 2019 | $1,332,000 | -35.0% | 14,507 | -9.9% | 0.10% | -21.8% |
Q2 2019 | $2,049,000 | -27.7% | 16,109 | -10.6% | 0.13% | -22.7% |
Q1 2019 | $2,834,000 | +39.7% | 18,015 | -11.9% | 0.17% | +73.7% |
Q4 2018 | $2,028,000 | -58.7% | 20,442 | -39.2% | 0.10% | -38.5% |
Q3 2018 | $4,912,000 | -7.0% | 33,644 | 0.0% | 0.16% | +8.1% |
Q2 2018 | $5,280,000 | – | 33,644 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |